Rui Zhang
Louisiana State University
26 Papers
71 Citations
Rui Zhang is an academic researcher from Louisiana State University. The author has contributed to research in topics: Radiation therapy & Proton therapy. The author has an hindex of 9, co-authored 26 publications. Previous affiliations of Rui Zhang include Mary Bird Perkins Cancer Center & University of Texas MD Anderson Cancer Center.
Chat about Author
Papers
An atlas-based method to predict three-dimensional dose distributions for cancer patients who receive radiotherapy
TL;DR: The results revealed that the proposed method was able to predict the 3D dose distributions accurately and can be used to improve planning quality and facilitate plan comparisons.
Cost-effectiveness analysis of radiotherapy techniques for whole breast irradiation
TL;DR: In this paper, a Markov model was developed to simulate health states for one cohort of women (65-year-old) with early-stage breast cancer over 15 years after WBRT.
Cost-effectiveness analysis of advanced radiotherapy techniques for post-mastectomy breast cancer patients
TL;DR: Advanced PMRT techniques are more cost- effective for breast cancer patients at a WTP threshold of $100,000/QALY, and IMRT might be a cost-effective option for PMRT patients.
Impact of Multileaf Collimator Configuration Parameters on the Dosimetric Accuracy of 6-MV Intensity-Modulated Radiation Therapy Treatment Plans.
TL;DR: The evaluation of selected configuration parameters that govern multileaf collimator (MLC) transmission and rounded leaf offset in a commercial treatment planning system (TPS) revealed that the overall dosimetric accuracy of the TPS depends on multiple configuration parameters in a manner that is coupled and not intuitive because of the commissioning protocol used in the authors' clinic.
Statistical Methods for Clinical Trial Designs in the New Era of Cancer Treatment.
Beibei Guo,Rui Zhang +1 more
TL;DR: Recent success of immunotherapy and other targeted therapies in cancer treatment has signaled the advent of precision medicine, and research development of clinical trial designs toward this trend is reviewed.
2